glp 1 agonist therapy Frontiers New GLP-1 Guidelines for Type

Tendons and ligaments: several studies on complete rat Achilles tendon sections reported improved biomechanical properties (tensile strength, elastic modulus) after subcutaneous BPC-157 treatment

Over-application doesn't improve results and may cause product pilling or stickiness

Symptoms I had after loading were spots everywhere , dizziness, nausea and fogginess in head which were all more extreme than before loading

Multiple clinical studies show EVOO increases postprandial GLP-1 and PYY (satiety hormones) while reducing ghrelin (the hunger hormone), through mechanisms that partially overlap with what GLP-1 drugs do pharmacologically